Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives. | Apoptosis | 2023 | 37095313 | PubTator, text mining | PubMed |
| Expression of Concern: The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis. | PLoS One | 2023 | 37093816 | PubTator, text mining | PubMed |
| Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors. | Ann Med | 2023 | 37092854 | PubTator, text mining | PubMed |
| IADVL SIG Pediatric Dermatology (Academy) Recommendations on Hemangioma of Infancy (HOI). | Indian Dermatol Online J | 2023 | 37089858 | PubTator, text mining | PubMed |
| Integrating multiple machine learning algorithms for prognostic prediction of gastric cancer based on immune-related lncRNAs. | Front Genet | 2023 | 37082204 | PubTator, text mining | PubMed |
| Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. | BMC Gastroenterol | 2023 | 37081402 | PubTator, text mining | PubMed |
| A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification. | BMC Gastroenterol | 2023 | 37081394 | PubTator, text mining | PubMed |
| Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor. | FEBS Open Bio | 2023 | 37079001 | PubTator, text mining | PubMed |
| LINC00562 drives gastric cancer development by regulating miR-4636-AP1S3 axis. | Korean J Physiol Pharmacol | 2023 | 37078294 | PubTator, text mining | PubMed |
| LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1α/NF-κB axis in psoriasis. | Cell Death Dis | 2023 | 37076497 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Potential Bladder Cancer Biomarkers: Take It or Leave It? | Int J Mol Sci | 2023 | 37047731 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma. | Int J Mol Sci | 2023 | 37047267 | PubTator, text mining | PubMed |
| Long non-coding RNA LINC00336 as an independent prognostic indicator and an oncogenic lncRNA in bladder cancer. | Arch Med Sci | 2023 | 37034517 | PubTator, text mining | PubMed |
| Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer. | Front Oncol | 2023 | 37025585 | PubTator, text mining | PubMed |
| Retraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically. | Mol Ther | 2023 | 37023757 | PubTator, text mining | PubMed |
| Molecular basis and therapeutic targets in prostate cancer: A comprehensive review. | Biomol Biomed | 2023 | 37021836 | PubTator, text mining | PubMed |
| Construction of a pancreatic cancer prediction model for oxidative stress-related lncRNA. | Funct Integr Genomics | 2023 | 37020128 | PubTator, text mining | PubMed |
| Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. | Cell Mol Biol Lett | 2023 | 37016296 | PubTator, text mining | PubMed |
| Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer. | Int J Immunopathol Pharmacol | 2023 | 37011378 | PubTator, text mining | PubMed |
| Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer. | Future Sci OA | 2023 | 37006229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=21